DrugDev’s Dr. Hugo Stephenson Establishes the DrugDev Innovation Lab with Partnerships with Two Cutting-Edge Technology Firms

12 Jun

DrugDev’s Dr. Hugo Stephenson Establishes the DrugDev Innovation Lab with Partnerships with Two Cutting-Edge Technology Firms

by TrialX Editor

DrugDev, a leading provider of technology driven solutions that help investigators, sponsors and CROs do more trials together, announced today the establishment of the DrugDev Innovation Lab, a technology incubator designed to accelerate emerging solutions in clinical trial automation. Led by DrugDev Executive Chairman Hugo Stephenson, MD, the DrugDev Innovation Lab will provide the expert guidance, capital resources and ecosystem necessary for smaller companies to scale their novel products into industry gold standard solutions.

Avatar
TrialX Editor
powerfunction@gmail.com
No Comments

Sorry, the comment form is closed at this time.